Table 2.

Criteria Required for a Biospecimen to Be Included in The Molecular Analysis Pipeline

Pathology review confirms that the correct target tissue has been obtained and comprises at least 50% of the sample (with few exceptions)

Pathology review confirms that the correct size of the target tissue has been obtained

Pathology review confirms that there is no presence of malignancy

RNA extracted from the biospecimen has at least 500 ng of total RNA

RNA extracted from the biospecimen has a RIN of 5.7 or higher